Cemiplimab,Thio-2'-Deoxyguanosine
MAIA Biotechnology,Regeneron,Sanofi 
[]
maia biotechnology to present design of thio-101 trial at european society for medical oncology (esmo) congress 2022 
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations.